ACCUNEB Drug Patent Profile

✉ Email this page to a colleague

When do Accuneb patents expire, and what generic alternatives are available?

Accuneb is a drug marketed by Norvium Bioscience and is included in one NDA.

The generic ingredient in ACCUNEB is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Accuneb

A generic version of ACCUNEB was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5^th, 1989.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ACCUNEB?
What are the global sales for ACCUNEB?
What is Average Wholesale Price for ACCUNEB?

Summary for ACCUNEB

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	81
Clinical Trials:	1
Patent Applications:	5,404
Drug Prices:	Drug price information for ACCUNEB
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ACCUNEB
DailyMed Link:	ACCUNEB at DailyMed

Drug patent expirations by year for ACCUNEB

Recent Clinical Trials for ACCUNEB

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Florida

See all ACCUNEB clinical trials

Paragraph IV (Patent) Challenges for ACCUNEB

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
ACCUNEB	Inhalation Solution	albuterol sulfate	0.021%	020949	1	2005-10-19
ACCUNEB	Inhalation Solution	albuterol sulfate	0.042%	020949	1	2004-04-06

US Patents and Regulatory Information for ACCUNEB

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Norvium Bioscience	ACCUNEB	albuterol sulfate	SOLUTION;INHALATION	020949-002	Apr 30, 2001		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Norvium Bioscience	ACCUNEB	albuterol sulfate	SOLUTION;INHALATION	020949-001	Apr 30, 2001		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ACCUNEB

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Norvium Bioscience	ACCUNEB	albuterol sulfate	SOLUTION;INHALATION	020949-002	Apr 30, 2001	⤷ Sign Up	⤷ Sign Up
Norvium Bioscience	ACCUNEB	albuterol sulfate	SOLUTION;INHALATION	020949-001	Apr 30, 2001	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ACCUNEB

See the table below for patents covering ACCUNEB around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	03037317		⤷ Sign Up
European Patent Office	1441709		⤷ Sign Up
Japan	2006513129		⤷ Sign Up
New Zealand	550304	An antimicrobial preservative-free albuterol inhalation solution for the relief of bronchospasm in children with asthma	⤷ Sign Up
China	1720036		⤷ Sign Up
Australia	2006202584		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ACCUNEB

Recent Clinical Trials for ACCUNEB

Paragraph IV (Patent) Challenges for ACCUNEB

Make Better Decisions: Try a trial or see plans & pricing